|
Through the development of enhanced chemical approaches that work with glycans and glycoconjugates, ADA enables the development of advanced human, animal, and plant health solutions. Learn more about how ADA’s technologies enable researchers to make cutting edge medical discoveries. ADA is developing platform technology to allow the direct targeting of and killing of cancer cells thus minimizing the negative side effects of systemic chemotherapy. Learn more about how ADA’s technology targets, images and then stages a multi-faceted attack on cancer. |
Cutting Edge Research for Better Lives
Leveraging our strengths in materials science and chemistry, ADA is developing cutting edge solutions to enable advanced research that will directly impact the health of patients. Our two largest areas of focus are glycomics and cancer treatment. ADA also develops proprietary methods and equipment to quantify chemicals in the body for the monitoring and treatment of patient health. With the focus on developing and commercializing technology, ADA’s researchers and business champions work hand in hand to understand industry and patient needs that match our core competencies. ADA’s core competencies in life biotechnology include:
|
 |
 |
